“…Caffeine, a non--selective adenosine receptor antagonist (Pelligrino et al, 2010), elicits: 1) neurostimulant effects, primarily via A1 receptors and the dopamine system (Ferre, 2008;Pelligrino et al, 2010); 2) cerebrovascular effects, primarily via A2A and A2B receptors located on blood vessels (Pelligrino et al, 2010); and 3) arousal enhancing effects, via A2A receptors and the histaminergic arousal system (Ferre, 2008); with tolerance thought to arise as the brain regulates its population of adenosine receptors to reach a new state of equilibrium in response to levels of caffeine chronically present in the body (Jacobson et al, 1996;Ralevic and Burnstock, 1998;Sousa et al, 2011). Studies have shown that administration of 200 --250 mg of caffeine results in reduced CBF (Addicott et al, 2009;Field et al, 2003;Laurienti et al, 2003;Liau et al, 2008;Mulderink et al, 2002;Perthen et al, 2008), possibly accompanied by a reduction in the baseline BOLD signal (during simple motor and visual tasks) (Chen and Parrish, 2009b;Perthen et al, 2008) and changes in the magnitude (Griffeth et al, 2011;Laurienti et al, 2002) and temporal dynamics of the BOLD response Liu et al, 2004;Rack--Gomer et al, 2009).…”